1. American Diabetes Association. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41:s7–12.
2. Djelmis J, Pavic M, Mulliqi Kotori V, Pavlic Renar I, Ivanisevic M, Oreskovic S. Prevalence of gestational diabetes mellitus according to IADPSG and NICE criteria. Int J Gynaecol Obstet. 2016;135:250–4.
3. Moyer VA. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:414–20.
4. Zhang F, Dong L, Zhang CP, Li B, Wen J, Gao W, et al. Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008. Diabet Med. 2011;28:652–7.
5. Leng J, Shao P, Zhang C, Tian H, Zhang F, Zhang S, et al. Prevalence of gestational diabetes mellitus and its risk factors in Chinese pregnant women: a prospective population-based study in Tianjin, China. PloS one. 2015;10:e0121029.
6. Yang X, Hsu-Hage B, Zhang H, Yu L, Dong L, Li J, et al. Gestational diabetes mellitus in women of single gravidity in Tianjin City, China. Diabetes Care. 2002;25:847–51.
7. Lowe WL Jr, Scholtens DM, Lowe LP, Kuang A, Nodzenski M, et al. Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity. JAMA. 2018;320:1005–16.
8. Zhang H. Mechanism associated with aberrant lncRNA MEG3 expression in gestational diabetes mellitus. Exp Ther Med. 2019;18:3699–706.
9. Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81.
10. Buchanan TA, Xiang AH, Page KA. Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol. 2012;8:639–49.
11. Kaseva N, Vaarasmaki M, Sundvall J, Matinolli HM, Sipola M, Tikanmaki M, et al. Gestational Diabetes But Not Prepregnancy Overweight Predicts for Cardiometabolic Markers in Offspring Twenty Years Later. J Clin Endocrinol Metab. 2019;104:2785–95.
12. Szmuilowicz ED, Josefson JL, Metzger BE. Gestational Diabetes Mellitus. Endocrinol Metab Clin North Am. 2019;48:479–93.
13. Trujillo ME, Scherer PE. Adipose tissue-derived factors: impact on health and disease. Endocr Rev. 2006;27:762–78.
14. Aoki K, Sun YJ, Aoki S, Wada K, Wada E. Cloning, expression, and mapping of a gene that is upregulated in adipose tissue of mice deficient in bombesin receptor subtype-3. Biochem Biophys Res Commun. 2002;290:1282–8.
15. Okada T, Nishizawa H, Kurata A, Tamba S, Sonoda M, Yasui A, et al. URB is abundantly expressed in adipose tissue and dysregulated in obesity. Biochem Biophys Res Commun. 2008;367:370–6.
16. Tremblay F, Revett T, Huard C, Zhang Y, Tobin JF, Martinez RV, et al. Bidirectional modulation of adipogenesis by the secreted protein Ccdc80/DRO1/URB. J Biol Chem. 2009;284:8136–47.
17. Tremblay F, Huard C, Dow J, Gareski T, Will S, Richard AM, et al. Loss of coiled-coil domain containing 80 negatively modulates glucose homeostasis in diet-induced obese mice. Endocrinology. 2012;153:4290–303.
18. Osorio-Conles O, Guitart M, Moreno-Navarrete JM, Escote X, Duran X, Fernandez-Real JM, et al. Adipose tissue and serum CCDC80 in obesity and its association with related metabolic disease. Mol Med. 2017;23:225–34.
19. Li L, Zhang Y, Du H, He P, Li G, Liu X, et al. Correlation between the expression level of coiled-coil domain-containing protein 80 and obesity. Zhonghua yu fang yi xue za zhi. 2015;49:248–53.
20. Hu J, Aris IM. Association of Total and Trimester-Specific Gestational Weight Gain Rate with Early Infancy Weight Status: A Prospective Birth Cohort Study in China. Nutrients. 2019;11.
21. Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676–82.
22. Bertolini G, D'Amico R, Nardi D, Tinazzi A, Apolone G. One model, several results: the paradox of the Hosmer-Lemeshow goodness-of-fit test for the logistic regression model. J Epidemiol Biostat. 2000;5:251–3.
23. Brusegan C, Pistocchi A, Frassine A, Della Noce I, Schepis F, Cotelli F. Ccdc80-l1 Is involved in axon pathfinding of zebrafish motoneurons. PloS one. 2012;7:e31851.
24. Paullin T, Powell C, Menzie C, Hill R, Cheng F, Martyniuk CJ, et al. Spheroid growth in ovarian cancer alters transcriptome responses for stress pathways and epigenetic responses. PLoS One. 2017;12:e0182930.
25. Pei G, Lan Y, Lu W, Ji L, Hua ZC. The function of FAK/CCDC80/E-cadherin pathway in the regulation of B16F10 cell migration. Oncol Lett. 2018;16:4761–7.
26. Ferraro A, Schepis F, Leone V, Federico A, Borbone E, Pallante P, et al. Tumor suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis. J Clin Endocrinol Metab. 2013;98:2834–43.
27. Grill JI, Neumann J, Ofner A, Marschall MK, Zierahn H, Herbst A, et al. Dro1/Ccdc80 inactivation promotes AOM/DSS-induced colorectal carcinogenesis and aggravates colitis by DSS in mice. Carcinogenesis. 2018;39:1176–84.
28. Rulifson IC, Karnik SK, Heiser PW, ten Berge D, Chen H, Gu X, et al. Wnt signaling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci U S A. 2007;104:6247–52.
29. Cavusoglu E, Kassotis JT, Anwar A, Marmur JD, Hussain SW, Yanamadala S, et al. Usefulness of Complement C1q to Predict 10-Year Mortality in Men With Diabetes Mellitus Referred for Coronary Angiography. Am J Cardiol. 2018;122:33–8.
30. Chikazawa M, Shibata T, Hatasa Y, Hirose S, Otaki N, Nakashima F, et al. Identification of C1q as a Binding Protein for Advanced Glycation End Products. Biochemistry. 2016;55:435–46.
31. Grill JI, Neumann J, Herbst A, Hiltwein F, Ofner A, Marschall MK, et al. DRO1 inactivation drives colorectal carcinogenesis in ApcMin/+ mice. Mol Cancer Res. 2014;12:1655–62.
32. Peng J, Lv YC, He PP, Tang YY, Xie W, Liu XY, et al. Betulinic acid downregulates expression of oxidative stress-induced lipoprotein lipase via the PKC/ERK/c-Fos pathway in RAW264.7 macrophages. Biochimie. 2015;119:192–203.
33. Gong D, Zhang Q, Chen LY, Yu XH, Wang G, Zou J, et al. Coiled-coil domain-containing 80 accelerates atherosclerosis development through decreasing lipoprotein lipase expression via ERK1/2 phosphorylation and TET2 expression. Eur J Pharmacol. 2019;843:177–89.
34. Kersten S. Physiological regulation of lipoprotein lipase. Biochim Biophys Acta. 2014;1841:919–33.
35. Marcantonio D, Chalifour LE, Alaoui-Jamali MA, Alpert L, Huynh HT. Cloning and characterization of a novel gene that is regulated by estrogen and is associated with mammary gland carcinogenesis. Endocrinology. 2001;142:2409–18.
36. Wadhwa PD, Buss C, Entringer S, Swanson JM. Developmental origins of health and disease: brief history of the approach and current focus on epigenetic mechanisms. Semin Reprod Med. 2009;27:358–68.